Tryptophan depletion in obsessive-compulsive patients

Biological Psychiatry

Volumn 40, Issue 5, 1996, Pages 398-402

  Smeraldi, Enrico ^a   Diaferia, Giuseppina ^a   Erzegovesi, Stefano ^a   Lucca, Adelio ^a   Bellodi, Laura ^a   Moja, Egidio A ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Amino acids; Depression; Mood; OCD; Serotonin; Tryptophan

Indexed keywords

TRYPTOPHAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPLETION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OBSESSION; PRIORITY JOURNAL;

EID: 0030248044     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00393-2     Document Type: Article

References (25)

1. Abbott FV, Etienne P, Franklin KBJ, Morgan MJ, Sewitch MJ, Young SN (1992): Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108:60-66.
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
3. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS (1992): The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies. J Clin Psychiatry 53(suppl 4):17-28.
4. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH (1994): Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 51:309-317.
5. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994): Mood-lowering effect of tryptophan depletion. Arch Gen Psychiatry 51:687-697.
6. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990): Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 47:411-418.
7. Dixon WJ (1990): BMDP Statistical Software Manual. Berkeley, Los Angeles: University of California Press.
8. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989a): Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison with placebo. Arch Gen Psychiatry 46:36-44.
9. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989b):The Yale-Brown Obsessive-Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 46:1006-1011.
10. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989c): The Yale-Brown Obsessive-Compulsive Scale: II. Validity. Arch Gen Psychiatry 46:1012-1016.
11. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
12. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR (1992): Serotonergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine response to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21-28.
13. Lucca A, Lucini V, Piatti E, Ronchi P, Smeraldi E (1992): Plasma tryptophan levels and plasma ratio tryptophan/neutral amino acids in patients with mood disorder, obsessive-compulsive disorder and normal subjects. Psychiatry Res 44:85-91.
14. Marcus S, Buke S, McEvoy L, Zeena T, Robins L (1990): NIMH Diagnostic Interview Schedule. Data entry and verification. Version 1.0 program. St. Louis, MO: Washington University School of Medicine.
15. Moja EA, Stoff DM, Gessa GL, Castoldi D, Assereto R, Tofanetti O (1988): Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. Life Sci 42: 1551-1556.
16. Moja EA, Cipolla P, Castoldi D, Tofanetti O (1989): Dose response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44:971-976.
17. Moja EA, Restani P, Corsini E, Stacchezzini MC, Assereto R, Galli CL (1991): Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. Life Sci 49:1121-1128.
18. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tollier TJ, Murphy DL (1990): Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: Behavioral and biological results. Arch Gen Psychiatry 47:926-932.
19. Robins LD, Helzer TE, Cottler L (1989): NIMH Diagnostic Interview Schedule. Version III-R (DIS III-R). St. Louis, MO: Washington University School of Medicine.
20. Rose WC (1949): Amino acid requirements of man. Fed Proc 8:546-552.
21. Smeraldi E, Erzegovesi S, Bianchi I, Pasquali S, Cocchi S, Ronchi P (1992): Fluvoxamine vs clomipramine treatment in obsessive-compulsive disorder: A preliminary study. New Trends Exp Clin Psychiatry 8:63-65.
22. Wurtman RJ, Hefti F, Melamed E (1981): Precursor control of neurotransmitter synthesis. Pharmacol Rev 32:315-335.
23. Young SN, Smith SE, Pihl RO, Ervin FR (1985): Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173-177.
24. Young SN, Ervin FR, Pihl RO, Finn P (1989): Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 98:508-511.
25. Zohar J, Mueller A, Insel TR, Zohar-Kadouch RC, Murphy DL (1987): Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44:946-951.